I have been an investor in the stock market and private businesses for over 15 years, and have dealt with numerous brokers of different sizes. I conducted research into Canary Capital several ago after I became aware they were corporate advisors for a stock I was carrying out due diligence on. From the moment I watched a short video involving Paul Hart, I was seriously impressed. Paul’s character reflected that of trust, deep knowledge & a level of astuteness I had not experienced in my investing career. I shortly after became a client of Canary’s, and the rest is history - We have had an outstanding run. Paul & Arun are a classy outfit, extremely professional, trustworthy, and highly intelligent. I am grateful to be a part of the Canary family.

K2fly has been involved with Canary Capital since 2017 and is delighted to recommend them as a trusted partner. On a personal level, I have benefitted greatly from their support, advice, and guidance in the last 4 years. They have helped establish K2fly as a significant Australian IT company on the ASX and they have worked tirelessly to promote the company to a wide range of investors.

We have been working with the team at Canary Capital for more than 3 years and they’ve always been there to support our business - in good times and also when we were unloved by the market. Canary Capital invested time to understand and buy into our business model, introducing patient and sophisticated investors who could also see what we were trying to build, often at times when the market was saying the opposite. They are a great fit for any small but aspirational early-stage business looking to access growth capital in the private and public arena where an emphasis on personal relationships and trust is paramount.

Canary Capital has worked with Exopharm (ASX:EX1) over the past 2 years – and particularly over the past 12 months. Over that time, Canary Capital has provided us a range of services and outcomes, all at the highest professional standard. My experience with Canary Capital has been very positive and they have demonstrated capabilities that match their promises time after time. As Exopharm evolves and grows, Canary Capital continues to provide important support and advice that we can rely upon and trust.

I’ve been with Canary from the beginning. Their sole focus is wealth creation for their clients and success for the companies they work with. Canary values their relationships, they invest alongside the client, on an ethical and communication level I’ve found them flawless. Their outstanding success is a testament to their skill, hard work, and perseverance in identifying undervalued companies and helping them become valuable ones.

I have dealt with Canary Capital since its inception and their knowledge and understanding of the microcap space is second to none. We have participated in numerous deals introduced by Canary that have done spectacularly well.

I am delighted to be able to provide a reference for Canary Capital and in doing so Arun and Paul. I have been with Canary from the beginning of the Canary journey. The sole focus of Paul and Arun is wealth creation for their clients whilst in parallel delivering successful solutions for the companies they work with. Canary (Arun and Paul) truly value their client relationships; they invest alongside clients and I have always found them highly ethical and extremely responsive in their availability for discussion on my specific investments all whilst providing an excellent level of overall communication on broader client portfolio information that is relevant to the companies they are supporting. Their prior and ongoing success is a testament to their skill, work ethic and perseverance in identifying undervalued companies and helping same become valuable companies whilst taking their clients along on that value-add journey. I have no hesitation in recommending Canary Capital as a partner in any wealth journey.